Outlook Therapeutics, Inc. (OTLK)

NASDAQ: OTLK · Real-Time Price · USD

0.4046

-0.0248 (-5.78%)

At close: Feb 9, 2026, 4:00 PM EST

0.4023

-0.0023 (-0.57%)

After-hours: Feb 9, 2026, 7:45 PM EST

Outlook Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 9, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	30	47	126	58	276	380
Market Cap Growth	-41.46%	-62.73%	119.64%	-79.15%	-27.49%	315.51%
Enterprise Value	52	73	127	59	260	372
Last Close Price	0.40	1.06	5.34	4.42	24.40	43.40
PS Ratio	9.96	33.31	-	-	-	-
PB Ratio	-	-1.46	-1.73	-3.98	31.58	82.58
P/TBV Ratio	-	-	-	-	31.58	82.58
EV/Sales Ratio	36.68	51.56	-	-	-	-
Debt / Equity Ratio	-0.94	-0.94	-0.41	-2.46	1.25	2.58
Asset Turnover	0.06	0.06	-	-	-	-
Quick Ratio	0.21	0.21	0.35	0.50	0.88	2.14
Current Ratio	0.38	0.38	0.64	0.66	1.40	3.19
Return on Equity (ROE)	-	-	-	-	-989.99%	-1430.33%
Return on Assets (ROA)	-176.82%	-176.82%	-146.63%	-109.17%	-153.56%	-151.98%
Return on Capital Employed (ROCE)	246.30%	246.30%	522.20%	368.10%	-716.90%	-322.10%
Earnings Yield	-209.89%	-132.58%	-59.66%	-102.55%	-23.94%	-13.97%
FCF Yield	-174.26%	-110.08%	-54.46%	-74.72%	-20.54%	-14.26%
Buyback Yield / Dilution	-87.59%	-87.59%	-48.29%	-17.96%	-38.91%	-110.43%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q